Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Number of holders
-
2,053
-
Total 13F shares, excl. options
-
1,017,132,506
-
Shares change
-
+177,080
-
Total reported value, excl. options
-
$86,349,876,202
-
Value change
-
+$21,706,246
-
Put/Call ratio
-
109%
-
Number of buys
-
1,030
-
Number of sells
-
-813
-
Price
-
$84.86
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2021
2,222 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q3 2021.
CVS HEALTH Corp - Common Stock (CVS) has 2,053 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,017,132,506 shares
of 1,268,585,398 outstanding shares and own 80.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (108,357,306 shares), BlackRock Inc. (94,594,948 shares), STATE STREET CORP (55,250,146 shares), Capital World Investors (50,573,988 shares), Capital International Investors (27,406,753 shares), MORGAN STANLEY (22,849,435 shares), GEODE CAPITAL MANAGEMENT, LLC (21,691,019 shares), JPMORGAN CHASE & CO (20,179,811 shares), Invesco Ltd. (18,011,567 shares), and BANK OF AMERICA CORP /DE/ (17,232,348 shares).
This table shows the top 2053 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.